The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction

Alternative Therapies in Health and Medicine

Volumn 13, Issue 2, 2007, Pages

  Houston, Mark C ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT THOMAS HOSPITAL   (United States)

^c Division of Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; HEAVY METAL; MERCURY;

ATHEROSCLEROSIS; CADMIUM POISONING; CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART INFARCTION; HYPERTENSION; ISCHEMIC HEART DISEASE; MERCURIALISM; OXIDATIVE STRESS; VASCULAR DISEASE;

CADMIUM; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; ENVIRONMENTAL POLLUTANTS; HUMANS; HYPERTENSION; MERCURY; METALS, HEAVY; MYOCARDIAL INFARCTION; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 33947275361     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (173)

1. Keating MH, Mahaffey KR, Schoemy R, et al. Mercury study report to Congress, Vol. I. Executive summary. EPA-452/R-97-003. Washington, DC: Environmental Protection Agency:1997.
2. Committee on the Toxicological Effects of Methylmercury, Board on Environmental Studies and Toxicology, Commission on Life Sciences. Toxicological effects of methylmercury. Washington, DC: National Research Council; 2000.
3. Magos L. Physiology and toxicology of mercury. Met Ions Biol Syst. 1997;34:321-370.
4. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731- 1737.
5. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347(22):1747-1754.
6. Keating MH, Mahaffey KR, Schoemy R, et al. Mercury study report to Congress, Vol. I. Executive summary. EPA-452/R-97-003. Washington, DC: Environmental Protection Agency: 1997.
7. Committee on the Toxicological Effects of Methylmercury, Board on Environmental Studies and Toxicology, Commission on Life Sciences. Toxicological effects of methylmercury. Washington, DC: National Research Council: 2000.
8. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731- 1737.
9. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347(22):1747-1754.
10. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731- 1737.
11. Ibid.
12. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731- 1737.
13. Ahlqwist M, Bengtsson C, Lapidus L, Gergdahl IA, Schutz A. Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand. I999;57(3):168-174.
14. Bergdahl IA, Schutz A, Ahlqwist M, et al. Methylmercury and inorganic mercury in serum-correlation to fish consumption and dental amalgam in a cohort of women born in 1922. Environ Res. 1998;77(1):20-24.
15. Keating MM, Mahaffey KR, Schoemy R, et al. Mercury study report to Congress, Vol. I. Executive summary. EPA-452/R-97-003. Washington, DC: Environmental Protection Agency; 1997.
16. Committee on the Toxicological Effects of Methylmercury, Board on Environmental Studies and Toxicology, Commission on Life Sciences. Toxicological effects of methylmercury. Washington, DC: National Research Council; 2000.
17. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731- 1737.
18. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347(22):1747-1754.
19. Keating MH, Mahaffey KR, Schoemy R, et al. Mercury study report to Congress, Vol. I. Executive summary. EPA-452/R-97-003. Washington, DC: Environmental Protection Agency; 1997.
20. Committee on the Toxicological Effects of Methylmercury, Board on Environmental Studies and Toxicology, Commission on Life Sciences. Toxicological effects of methylmercury. Washington, DC: National Research Council; 2000.
21. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731- 737.
22. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347(22):1747-1754.
23. Keating MH, Mahaffey KR, Schoemy R, et al. Mercury study report to Congress, Vol. I. Executive summary. EPA-452/R-97-003. Washington, DC: Environmental Protection Agency; 1997.
24. Committee on the Toxicological Effects of Methylmercury, Board on Environmental Studies and Toxicology, Commission on Life Sciences. Toxicological effects of methylmercury. Washington, DC: National Research Council; 2000.
25. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731- 1737.
26. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, iish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347(22):1747-1754.
27. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-655.
28. Yoshizawa K, Rimm EB, Morris JS, et al. Mercury and the risk of coronary heart disease in men. N Engl J Med. 2002;347(22):1755-1760.
29. Chmielnicka J, Bem EM, Kaszubski P. Organ and subcellular distribution of cadmium in rats exposed to cadmium, mercury, and selenium. Environ Res. 1983;31(2):266-272.
30. Komsta-Szumska E, Chmielnicka J. Effects of zinc, cadmium or copper on mercury distribution in rat tissues. Toxicol Lett. 1983;17(3-4):349-354.
31. International Programme on Chemical Safety (IPCS). Methylmercury. Environmental Health Criteria 101. Geneva: World Health Organization; 1990.
32. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-655.
33. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-655.
34. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148(2):265-273.
35. International Programme on Chemical Safety (IPCS). Mcthylmercury. Environmental Health Criteria 101. Geneva: World Health Organization, 1990.
36. Yoshizawa K, Rimm EB, Morris JS, et al. Mercury and the risk of coronary heart disease in men. N Engl J Med. 2002;347(22):1755-1760.
37. Parizek J, Ostadalova I. The protective effect of small amounts of selenite in sublimate intoxication. Experimentia. 1967;23(2):142-143.
38. Ganther HE, Goudie C, Sunde ML, Kopecky MJ, Wagner P. Selenium: relation to decreased toxicity of methylmercury added to diets containing tuna. Science. 1972;175(26):1122-1124.
39. Ganther HE, Sunde ML. Effect of tuna fish and selenium on the toxicity of methylmercury: a progress report. J Food Sci. 1974;39:1-5.
40. Stoewsand GS, Bache CA, Lisk DJ. Dietary selenium protection of methylmercury intoxication of japanese quail. Bull Environ Contam Toxicol. 1974;11(2):152-156.
41. Sumino K, Yamamoto R, Kitamura SA. A Role of selenium against methylmercury toxicity. Nature. 1977;268(5615):73-74.
42. Singhal RK, Anderson ME, Meister A. Glutathione, a first line of defense against cadmium toxicity. FASEB J. 1987;1(3):220-223.
43. Seppanen K, Kantola M, Laatikainen R, et al. Effect of supplementation with organic seienium on mercury status as measured by mercury in pubic hair. J Trace Elem Med Biol. 2000;14(2):84-87.
44. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45(10):2017-2024.
45. Shenker BJ, Guo TL, Shapiro IM. Low-level methylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction. Environ Res. 1998;77(2):149-159.
46. Peraza MA, Ayala-Fierro F, Barber DS, Casarez E, Rael LT. Effects of micronutrients on metal toxicity. Environ Health Perspect. 1998;106(Suppl 1):203-216.
47. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45(10):2017-2024.
48. Shenker BJ, Guo TL, Shapiro IM. Low-level methylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction. Environ Res. 1998;77(2):149-159.
49. Peraza MA, Ayala-Fierro F, Barber DS, Casarez E, Rael LT. Effects of micronutrients on metal toxicity. Environ Health Perspect. 1998;106(Suppl 1):203-216.
50. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-655.
51. Ibid.
52. Ibid.
53. Magos L. Physiology and toxicology of mercury. Met Ions Biol Syst. 1997;34:321-370.
54. Jansson G, Harms-Ringdahl M. Stimulating effects uf mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic Res Commun. 1993;18(2):87-98.
55. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci. 1997;34(4):369-403.
56. Insug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology. 1997;124(30):211-224.
57. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45(10):2017-2024.
58. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17(4):261-274.
59. Park ST, Lim KT, Chung YT, Kim SU. Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology. 1996;17(1):37-45.
60. Miller DM, Lund BO, Woods JS. Reactivity of Hg(II) with superoxide: evidence for the catalytic dismutation of superoxide by Hg(II). J Biochem Toxicol. 1991;6(4):293-298.
61. Magos L. Physiology and toxicology of mercury. Met Ions Biol Syst. 1997;34:321-370.
62. Jansson G, Harms-Ringdahl M. Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic Res Commun. 1993;18(2):87-98.
63. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci. 1997;34(4):369-403.
64. Magos L. Physiology and toxicology of mercury. Met Ions Biol Syst. 1997;34:321-370.
65. Jansson G, Harms-Ringdahl M. Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic Res Commun. 1993;18(2):87-98.
66. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci. 1997;34(4):369-403.
67. Naganuma A, Koyama Y, Imura N. Behavior of methylmercury in mammalian erythrocytes. Toxicol Appl Pharmacol. 1980;54(3):405-410.
68. Insug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology. 1997;124(30):211-224.
69. Magos L. Physiology and toxicology of mercury. Met Ions Biol Syst. 1997;34:321-370.
70. Jansson G, Harms-Ringdahl M. Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic Res Commun. 1993;18(2):87-98.
71. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci. 1997;34(4):369-403.
72. Cuvin-Aralar ML, Furness RW. Mercury and selenium interaction: a review. Ecotoxicol Environ Saf. 1991;21(3):348-364.
73. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17(4):261-274.
74. Naganuma A, Koyama Y, Imura N. Behavior of methylmercury in mammalian erythrocytes. Toxicol Appl Pharmacol. 1980;54(3):405-410.
75. Insug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology. 1997;124(30):211-224.
76. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45(10):2017-2024.
77. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17(4):261-274.
78. Rungby J, Ernst E. Experimentally induced lipid peroxidation after exposure to chromium, mercury or silver: interactions with carbon tetrachloride. Pharmacol Toxicol. 1992;70(3):205-207.
79. Park ST, Lim KT, Chung YT, Kim SU. Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology. 1996;17(1):37-45.
80. Huang YL, Cheng SL, Lin TH. Lipid peroxidation in rats administered with mercuric chloride. Biol Trace Elem Res. 1996;52(2):193-206.
81. Lin TH, Huang YL, Huang SF. Lipid peroxidation of rats administered with methyl mercuric chloride. Biol Trace Elem Res. 1996;54(1):33-41.
82. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-655.
83. Kostka B. Kinetic evaluation of ADP-induced platelet aggregation potentiation by methylmercuric chloride. J Trace Elem Exp Med. 1991;4:1-9.
84. Jansson G, Harms-Ringdahl M. Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic Res Commun. 1993;18(2):87-98.
85. Kostka B, Kinetic evaluation of ADP-induced platelet aggregation potentiation by met hylmercuric chloride. J Trace Elem Exp Med 1991;4:1-9.
86. Wierzbicki R, Prazanowski M, Michalska M, Krajewska U, Mielicki WP. Disorders in blood coagulation in humans occupationally exposed to mercuric vapors. J Trace Elem Exp Med. 2002;15(1):21-29.
87. Kishimoto T, Oguri T, Abe M, Kajitani H, Tada M. Inhibitory effect of methylmercury on migration and tube formation by cultured human vascular endothelial cells. Arch Toxicol. 1995;69(6):357-361.
88. Insug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology. 1997;124(30):211-224.
89. Ibid.
90. Ibid.
91. Ibid.
92. Jansson G, Harms-Ringdahl M. Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic Res Commun. 1993;18(2):87-98.
93. Insug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology. 1997;124(30);211-224.
94. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45(10):2017-2024.
95. Shenker BJ, Guo TL, Shapiro IM. Low-level methylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction. Environ Res. 1998;77(2):149-159.
96. Peraza MA, Ayala-Fierro F, Barber DS, Casarez E, Rael LT. Effects of micronutrients on metal toxicity. Environ Health Perspect. 1998;106(Suppl 1):203-216.
97. Insug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology. 1997;124(30):211-224.
98. Lu KP, Zhao SM, Wang DS. The stimulatory effect of heavy metal cations on proliferation of aortic smooth muscle cells. Sci China B. 1990;33(3):303-310.
99. Gonzalvo MC, Gil F, Hernandez AF, Villanueva E, Pla A. Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem Biol Interact. 1997;105(3):169-179.
100. Salonen JT, Malin R, Thomainen TP, Nyyssonen K, Lakka TA, Lehtimaki T. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. BMJ. 1999;319(7208):487-488.
101. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58(7):461-466.
102. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148(2):265-273.
103. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17(4):201-274.
104. Torres AD, Rai AN, Hardiek ML. Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics. 2000;105(3):E34.
105. Barregard L, Sallsten G, Jarvholm B. Mortality and cancer incidence in chloralkali workers exposed to inorganic mercury. Br J Ind Med. 1990;47(2):99-104.
106. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347(22):1747-1754.
107. Ganther HE, Goudie C, Sunde ML, Kopecky MJ, Wagner P. Selenium: relation to decreased toxicity of methylmercury added to diets containing tuna. Science. 1972;175(26):1122-1124.
108. Barregard L, Sallsten G, Jarvholm B. Mortality and cancer incidence in chloralkali workers exposed to inorganic inerairy. Br J Ind Med. 1990;47(2):99-104.
109. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortalitv from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58(7):461-466.
110. Singhal RK, Anderson ME, Meister A. Glutathione, a first line of defense against cadmium toxicity. FASEB J. 1987;1(3):220-223.
111. Salonen JT, Seppanen K, Lakka TA, Salonen K, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148(2):265-273.
112. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58:461-466.
113. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731- 1737.
114. Ibid.
115. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58(7):461-466.
116. Wojciechowski J, Kowalski W. Cardiac and aortic lesions in chronic experimental poisoning with mercury vapors. Pol Med Sci Hist Bull. 1975;15(2):255-260.
117. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347(22):1747-1754.
118. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, Salonen JT. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation. 2000;102:2677-2679.
119. Yoshizawa K, Rimm EB, Morris JS, et al. Mercury and the risk ol coronary heart disease in men. N Engl J Med. 2002;347(22):1755-1760.
120. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-655.
121. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58(7):461-466.
122. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17(4):261-274.
123. Torres AD, Rai AN, Hardiek ML. Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics. 2000;105(3):E34.
124. Ahlqwist M, Bengtsson C, Lapidus L, Gergdahl IA, Schutz A. Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand. 1999;57(3):168-174.
125. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17(4):261-274.
126. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58(7):461-466.
127. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-655.
128. Ahlqwist M, Bengtsson C, Lapidus L, Gergdahl IA, Schutz A. Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand. 1999;57(3):168-174.
129. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148(2):265-273.
130. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58(7):461-466.
131. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148(2):265-273.
132. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17(4):261-274.
133. Torres AD, Rai AN, Hardiek ML. Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics. 2000;105(3):E34.
134. Kobal AB, Horvat M, Prezelj M, et al. The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners. J Trace Elem Med Biol. 2004;17(4):261-274.
135. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148(2):265-273.
136. Torres AD, Rai AN, Hardiek ML. Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics. 2000;105(3):E34.
137. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Modality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58(7):461-466.
138. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45(10):2017-2024.
139. Kohal AB, Flisar Z, Miklavcic V, Dizdarevic T, Sesek-Briski A. Renal function in miners intermittently exposed to elemental mercury vapour. Arh Hig Rada Toksikol 2000;51(4):369-380.
140. Torres AD, Rai AN, Hardiek ML. Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics. 2000;105(3):E34.
141. Boffetta P, Sallsten G, Garcia-Gomez M, et al. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med. 2001;58(7):461-466.
142. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45(10):2017-2024.
143. Kobal AB, Flisar Z, Miklavcic V, Dizdarevic T, Sesek-Briski A. Renal function in miners intermittently exposed to elemental mercury vapour. Arh Hig Rada Toksikol 2000;51(4):369-380.
144. Revis NW, Zinsmeister AR, Bull R. Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion. Proc Natl Acad Sci U S A. 1981;78(10):6494-6498.
145. Hallenbeck WH. Human health effects of exposure to cadmium. Experientia. 1984;40(2):136-142.
146. Spieker C, Zidek W, Zumkley H. Cadmium and hypertension. Nephron. 1987;47(Suppl 1):34-36.
147. Kopp SJ, Perry HM Jr, Perry FF, Erlanger M. Cardiac physiologic and tissue metabolic changes following chronic low-level cadmium and cadmium plus lead ingestion in the rat. Toxicol Appl Pharmacol. 1983;69(1):149-160.
148. Kristensen TS. Cardiovascular diseases and the work environment. A critical review of the epidemiologic literature on chemical factors. Scand J Work Environ Health. 1989;15:245-264.
149. Baker JR, Satarug S, Fdwards RJ, Moore MR, Williams DJ, Reilly PE. Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity. Toxicol Lett. 2003;137(1-2):85-93.
150. Brzoska MM, Moniuszko-Jakoniuk J. The influence of calcium content in diet on cumulation and toxicity of cadmium in the organism. Arch Toxicol. 1998;72:63-73.
151. Subramanyam G, Bhaskar M, Govindappa S. The role of cadmium in induction of atherosclerosis in rabbits. Indian Heart J. 1992;44(3):177-180.
152. Hallenbeck WH. Human health effects of exposure to cadmium. Experientia. 1984;40(2):136-142.
153. Ibid.
154. Ibid.
155. Ibid.
156. Ibid.
157. Ibid.
158. Ibid.
159. Brzoska MM, Moniuszko-Jakoniuk J. The influence of calcium content in diet on cumulation and toxicity of cadmium in the organism. Arch Toxicol. 1998;72:63-73.
160. Ibid.
161. Revis NW, Zinsmeister AR, Bull R. Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion. Proc Natl Acad Sci U S A. 1981;78(10):6494-6498.
162. Hallenbeck WH. Human health effects of exposure to cadmium. Experientia. 1984;40(2):136-142.
163. Kopp SJ, Perry HM Jr, Perry EF, Erlanger M. Cardiac physiologic and tissue metabolic changes following chronic low-level cadmium and cadmium plus lead ingestion in the rat. Toxicol Appl Pharmacol. 1983;69(1):149-160.
164. Brzoska MM, Moniuszko-Jakoniuk J. The influence of calcium content in diet on cumulation and toxicity of cadmium in the organism. Arch Toxicol. 1998;72:63-73.
165. Subramanyam G, Bhaskar M, Govindappa S. The role of cadmium in induction of atherosclerosis in rabbits. Indian Heart J. 1992;44(3):177-180
166. Hallenbeck WH. Human health effects of exposure to cadmium. Experientia. 1984;40(2):136-142.
167. Spieker C, Zidek W, Zumkley H. Cadmium and hypertension. Nephron. 1987;47(Suppl 1):34-36.
168. Kristensen TS. Cardiovascular diseases and the work environment. A critical review of the epidemiologic literature on chemical factors. Scand J Work Environ Health. 1989;15:245-264.
169. Hallenbeck WH. Human health effects of exposure to cadmium. Experientia. 1984;40(2):136-142.
170. Kristensen TS. Cardiovascular diseases and the work environment. A critical review of the epidemiologic literature on chemical factors. Scand J Work Environ Health. 1989;15:245-264.
171. Baker JR, Satarug S, Edwards RJ, Moore MR, Williams DJ, Reilly PE. Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity. Toxicol Lett. 2003;137(1-2):85-93.
172. Ibid.
173. Ibid.